Virpax Pharmaceuticals Pink Sheet Forecast - Relative Strength Index
| VRPX Stock | USD 0.01 0.0001 0.91% |
Virpax Pink Sheet outlook is based on your current time horizon.
At this time, the relative strength index (RSI) of Virpax Pharmaceuticals' share price is approaching 46. This entails that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Virpax Pharmaceuticals, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
Using Virpax Pharmaceuticals hype-based prediction, you can estimate the value of Virpax Pharmaceuticals from the perspective of Virpax Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Virpax Pharmaceuticals after-hype prediction price | USD 0.0106 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Virpax |
Virpax Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Virpax price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Virpax using various technical indicators. When you analyze Virpax charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 46.68 | 46.68 |
| Check Virpax Pharmaceuticals Volatility | Backtest Virpax Pharmaceuticals | Information Ratio |
Virpax Pharmaceuticals Trading Date Momentum
| On January 27 2026 Virpax Pharmaceuticals was traded for 0.01 at the closing time. The top price for the day was 0.01 and the lowest listed price was 0.01 . The trading volume for the day was 629. The trading history from January 27, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.00% . |
| Compare Virpax Pharmaceuticals to competition |
Other Forecasting Options for Virpax Pharmaceuticals
For every potential investor in Virpax, whether a beginner or expert, Virpax Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Virpax Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Virpax. Basic forecasting techniques help filter out the noise by identifying Virpax Pharmaceuticals' price trends.Virpax Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Virpax Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Virpax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Virpax Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Virpax Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Virpax Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Virpax Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Virpax Pharmaceuticals pink sheet market strength indicators, traders can identify Virpax Pharmaceuticals entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 0.0111 | |||
| Day Typical Price | 0.0111 | |||
| Price Action Indicator | 1.0E-4 | |||
| Period Momentum Indicator | 1.0E-4 | |||
| Relative Strength Index | 46.68 |
Virpax Pharmaceuticals Risk Indicators
The analysis of Virpax Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Virpax Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting virpax pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 67.05 | |||
| Standard Deviation | 238.65 | |||
| Variance | 56953.35 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Virpax Pharmaceuticals
The number of cover stories for Virpax Pharmaceuticals depends on current market conditions and Virpax Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Virpax Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Virpax Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Virpax Pharmaceuticals Short Properties
Virpax Pharmaceuticals' future price predictability will typically decrease when Virpax Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Virpax Pharmaceuticals often depends not only on the future outlook of the potential Virpax Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Virpax Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.3 M | |
| Cash And Short Term Investments | 1.5 B |
Additional Tools for Virpax Pink Sheet Analysis
When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.